" Mesoblast (ASX:MSB) granted approval for COVID-19 trial in US
Medtech developer Mesoblast (MSB) has been approved to trial its novel remestemcel-L treatment for COVID-19 related acute respiratory distress syndrome (ARDS) in the
" Dacian Gold (ASX:DCN) $98M equity raise to recapitalise struggling miner
Dacian Gold (DCN) is hoping to raise around $98 million from a share placement and entitlement offer as part of the company’s recapitalisation
" G Medical’s (ASX:GMV) Prizma device granted U.S. over-the-counter approval
Meditech innovator G Medical (GMV) has been granted special FDA approval for non-prescription, over-the-counter use of its Prizma device in the US.
" Peak Resources (ASX:PEK) shareholders fuming after being left out of bargain placement
Rare earth explorer Peak Resources (PEK) has received binding commitments for its $1.5 million placement and some investors are fuming after being lef…